GSK gives up on rare diseases as gene therapy gets two customers

LONDON (Reuters) - GlaxoSmithKline is swimming against the tide by getting out of treatments for rare diseases at a time when rivals like Sanofi and Shire see the field as a rich seam for profits.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news